Compare Mutual Funds
Bajaj Finserv Healthcare Fund
EquitySectoral-Pharma
Select a Mutual Fund
Risk
Very High
-
Rating
-
-
Min SIP Amount
₹500
-
Expense Ratio
2.59
-
NAV
₹11.70
-
Fund Started
06 Dec 2024
-
Fund Size
₹405.14 Cr
-
Exit Load
1% for redemption within 3 Months
-
1 Year
15.37%
-
3 Year
-
-
5 Year
-
-
Equity
95.56%
-
Cash
2.12%
-
Top 10 Holdings
Name | Assets |
|---|---|
Divi's Laboratories Ltd. | 9.75% |
Sun Pharmaceutical Industries Ltd. | 8.96% |
Piramal Pharma Ltd. | 6.36% |
Rubicon Research Ltd. | 6.08% |
Aurobindo Pharma Ltd. | 6.03% |
Apollo Hospitals Enterprise Ltd. | 5.51% |
Torrent Pharmaceuticals Ltd. | 4.78% |
Emcure Pharmaceuticals Ltd. | 4.03% |
Laurus Labs Ltd. | 3.91% |
Neuland Laboratories Ltd. | 3.82% |
-
Name
-
-
Start Date
-
-
Description
The Scheme seeks to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies.
-
Launch Date
06 Dec 2024
-
